Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Menú Volver a 06

Track 6: Preclinical Development and Early-Phase Clinical Research

DIA 2017: Driving Insights to Action

Preclinical and early-phase clinical research provide initial safety, tolerability, and efficacy data for new drugs. This track focuses on topics ranging from early-stage compound selection, PK, and safety considerations for both drugs and biologics, as well as dosing strategies to data integrity for proper downstream decision-making.

Sessions in Preclinical Development and Early-Phase Clinical Research

Sunday, June 24 | Short Courses

View All Short Courses

Monday, June 25

Tuesday, June 26

Wednesday, June 27

Thursday, June 28

Who is This Track Designed For?

Professionals involved in: pharmacology and toxicology, nonclinical safety testing, clinical research, clinical operations, safety and pharmacovigilance, project management, patient centricity, and statistics; formulation science, pharmacokinetics/pharmacodynamics, epidemiology, toxicology, and regulatory affairs..

View Other Tracks


Registration Rates

Back to DIA 2018

Back to DIAglobal.org


Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.